Problematic recreational drug use: is there a role for outpatient sexual health clinics in identifying those not already engaged with treatment services?

Sexual Health ◽  
2015 ◽  
Vol 12 (6) ◽  
pp. 501 ◽  
Author(s):  
Caitlyn Lovett ◽  
T. Yamamoto ◽  
Laura Hunter ◽  
John White ◽  
Paul I. Dargan ◽  
...  

Background There is an association between recreational drug use, high-risk sexual activity and sexually transmissible infections. Studies have shown a higher prevalence of drug use in those accessing sexual health services; however, there are minimal data on the proportion with problematic recreational drug use. We aimed to understand whether sexual health clinics could identify problematic drug and alcohol use as a novel referral pathway into treatment services. Methods: Males attending two sexual health clinics in London completed questionnaires. Data were collected on demographics; gender of sexual partner; use of alcohol and recreational drugs; if they felt they had problematic use of drugs, alcohol or both; and if they had sought help for their problematic use. Results: In total, 867 males completed the questionnaire; 387 (44.7%) were men who have sex with men (MSM). MSM had significantly higher lifetime use of any drug compared with non-MSM (80.6% vs. 62.5%; P < 0.0001). Thirty-five (4.7%) self-identified problematic drug or alcohol use, with no difference between MSM and non-MSM (6.3% vs. 3.5%; P = 0.08). Of those with problematic drug or alcohol use, 20 were currently or had been engaged with a treatment service and 15 had never engaged with treatment services. MSM were more likely to have ever sought help for drug or alcohol problems compared with non-MSM (P = 0.003). Conclusions: Some individuals attending sexual health clinics with problematic drug use have not engaged with treatment services. It is therefore appropriate to develop screening tools for sexual health clinics to identify these individuals and novel referral pathways to engage them in treatment services.

2016 ◽  
Vol 92 (Suppl 1) ◽  
pp. A67.3-A68
Author(s):  
Andrew Tomkins ◽  
Sameena Ahmad ◽  
Luke Cannon ◽  
Stephen P Higgins ◽  
Merav Kilner ◽  
...  

2016 ◽  
Vol 28 (4) ◽  
pp. 362-366 ◽  
Author(s):  
A Hegazi ◽  
MJ Lee ◽  
W Whittaker ◽  
S Green ◽  
R Simms ◽  
...  

The objective of this study was to analyse associations between sexualised substance use (chemsex), STI diagnoses and sexual behaviour among gay bisexual and other men who have sex with men accessing sexual health clinics to better inform clinical pathways. A retrospective case notes review was undertaken following the introduction of more detailed and holistic profomas for all gay bisexual and other men who have sex with men attending two London sexual health clinics between 1 June 2014 and 31 January 2015. Chemsex status was documented for 655/818. Overall, 30% disclosed recreational drug use of whom 113 (57%) disclosed chemsex and 27 (13.5%) injecting drugs. HIV-positive gay bisexual and other men who have sex with men were more likely to disclose chemsex (AOR 6.68; 95% CI 3.91–11.42; p < 0.001). Those disclosing chemsex had a higher incidence of acute bacterial STIs (AOR 2.83 CI 1.79–4.47; p < 0.001), rectal STIs (AOR 3.10 CI 1.81–5.32; p < 0.001) or hepatitis C (AOR 15.41 CI 1.50–158.17; p = 0.021). HIV incidence in the study period was 1.8% (chemsex) vs. 0.9% (no chemsex) (p = 0.61). Chemsex was associated with having more sexual partners, transactional sex, group sex, fisting, sharing sex toys, injecting drug use, higher alcohol consumption and the use of ‘bareback’ sexual networking applications (p < 0.004). Chemsex participants were also more likely to have accessed post-exposure prophylaxis for HIV in the study period and report sex with a discordant HIV or hepatitis C-infected partner (p < 0.001). Chemsex disclosure is associated with higher risk-taking behaviours, acute bacterial STIs, rectal STIs and hepatitis C incidence. HIV incidence was higher but not significantly so in the study period. Chemsex disclosure in sexual health clinics should prompt an opportunity for prevention, health promotion and wellbeing interventions.


2019 ◽  
Vol 25 (3) ◽  
pp. 421-437 ◽  
Author(s):  
Clay Darcy

The purpose of this article is to explore the motivations behind some men’s recreational use of illicit drugs from a gender standpoint. The rationale for this analysis stems from men’s predominance as illicit drug users and their likelihood of experiencing problem drug use and becoming a part of an over-represented population in drug treatment services. Explanations for men’s problematic/addicted patterns of drug use often point to marginalisation, disadvantage, and/or men’s tendency towards problematic health behaviours. This article argues that men’s illicit recreational drug use is often glossed over as a gendered activity and receives less scrutiny than problematic/addicted patterns of drug taking. It examines the drug-taking motivations of 20 Irish men who identified as illicit recreational drug users to expand on and deepen current explanations for men’s illicit recreational drug use. The article demonstrates how men engage in drug use for complex and contradictory reasons that include embodied quests for pleasure and excitement, achieving connection with other men, and performing or contravening masculinities in homosocial contexts.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sara Abu Zaki ◽  
Jihane Naous ◽  
Antoine Ghanem ◽  
Diana Abou Abbas ◽  
Roland Tomb ◽  
...  

AbstractAccess to sexual and reproductive health in conservative communities and in the MENA region are particularly limited and, as such, increase women’s vulnerability to unwanted pregnancies, unsafe abortions, and sexually transmitted infections (STIs). The aim was to assess the prevalence of STIs, sexual practices, recreational drug-use and their possible associations among cisgender unmarried women residing in Lebanon. Data on demographics, sexual practices and substance-use were collected from 2083 unmarried cisgender women who voluntarily attended a sexual health clinic in Lebanon between 2015 and 2019. They tested for HIV, Hepatitis B, Hepatitis C and Syphilis through rapid testing. Other infections (genital warts, Neisseria gonorrhea/Chlamydia trachomatis) were screened for. Regression models were computed between variables. There were two cases of HIV, one of Hepatitis B and syphilis, and no cases of Hepatitis C. Genital warts were present in 15% and symptoms indicative of Neisseria gonorrhea/Chlamydia trachomatis in 14%. Inconsistent condom-use (81%) was significantly associated with number of partners (adj. OR: 0.4). Inconsistent condom-use discussion with partners (33%) was significantly associated with unemployment (adj OR: 1.7), recreational drug-use (adj. OR: 1.4), and number of partners (adj. ORs 3.7–4.4). Unwanted pregnancies (11%) were significantly associated with age (adj. ORs 0.1–0.37), recreational drug-use (adj. OR: 2), using intrauterine device (adj. OR:2.9) and natural birth control methods (adj. OR: 2.4). Recreational drug-use (33%) was significantly associated with age (adj ORs 1.9–2.2), and smoking status (adj. OR: 0.6). The results indicate an urgent need for: (1) Accessible, non-stigmatizing, and inclusive sexual health services dedicated to women’s sexual health; (2) Comprehensive and non-stigmatizing sexual health education for all, but especially women, in order to promote safer sexual practices and effective decision making with regards to contraception and condom-use.


2016 ◽  
Vol 92 (6) ◽  
pp. 454-454 ◽  
Author(s):  
Hamish Mohammed ◽  
John Were ◽  
Carina King ◽  
Martina Furegato ◽  
Anthony Nardone ◽  
...  

2017 ◽  
Vol 29 (4) ◽  
pp. 350-356 ◽  
Author(s):  
A Tomkins ◽  
S Ahmad ◽  
L Cannon ◽  
SP Higgins ◽  
M Kliner ◽  
...  

Recreational drug use (RDU) has been reported to be disproportionately higher in men who have sex with men (MSM) when compared to their heterosexual counterparts. To identify RDU, links to risky sexual practices and infections for MSM attending three sexual health clinics across Manchester, United Kingdom, a retrospective case note review was conducted using a random powered sample of service users attending three sites during 2014. Three hundred and fifty-seven case notes were reviewed across three sites. Eighteen per cent of service users reported any type of RDU. Use of at least one of the three drugs associated with chemsex (crystal methamphetamine, mephedrone, gamma hydroxybutyrate/gamma butyrolactone) was reported by 3.6%. A statistically significant difference was identified between non-drug users and any-drug users reporting: group sex (odds ratio [OR] 5.88, p = 0.013), condomless receptive anal intercourse (CRAI) (OR 2.77, p = 0.003) and condomless oral intercourse (OR 2.52, p = 0.016). A statistically significant difference was identified between chemsex-related drug user and non-drug user groups reporting: group sex (OR 13.05, p = 0.023), CRAI (OR 3.69, p = 0.029) and condomless insertive anal intercourse (OR 1.27, p = 0.039). There was also a statistically higher incidence of gonorrhoea infection in chemsex-related drug use compared with those not using drugs (p = 0.002, OR 6.88). This study identifies that substance use is common in MSM attending sexual health clinics in Manchester. High-risk sexual practices and certain sexually transmitted infections are more common in MSM reporting RDU.


Sign in / Sign up

Export Citation Format

Share Document